The Spatial Genomics & Transcriptomics Market Size is valued at USD 238.84 Mn in 2022 and is predicted to reach USD 667.51 Mn by the year 2031 at a 12.3% CAGR during the forecast period for 2023-2031.
Advanced molecular biologies methods like spatial genomics and transcriptomics are used to examine the spatial organization and patterns of gene expression in tissues and cells. These methods offer insightful information about the connections between genes, their activity, and their actual locations within intricate biological systems. There is an increasing need for the application of spatial genomics and transcriptomics in drug discovery and development.
The focus of this demand has recently shifted from research to drug discovery and development, notably for diseases like cancer and neurological illnesses. The launch of the fourth generation of sequencing and the growing potential of spatial genomic analysis as a cancer diagnosis tool is expected to further fuel the rise.
However, the COVID-19 outbreak has hampered operations in the global healthcare industry. Several companies, including certain sectors within the healthcare industry, have had to temporarily cease operations due to the illness. The market for spatial genomics and transcriptomics saw a contraction as a result of the global economic slowdown induced by the COVID-19 pandemic in 2020. The COVID-19 pandemic has resulted in supply chain disruptions in various sectors, such as academic and research, pharmaceutical, and biotechnology industries.
Competitive Landscape
Some major key players in the Spatial Genomics & Transcriptomics Market:
- 10x Genomics
- NanoString Technologies
- Illumina
- Fluidigm Corporation
- PerkinElmer
- Akoya Biosciences (formerly known as CytoViva)
- Spatial Transcriptomics
- Dovetail Genomics (Part of Illumina)
- S2 Genomics
- Visiopharm
- MGI Tech Co. Ltd.
- CARTANA
- RareCyte
- Horizon Discovery Group
- IONpath
Market Segmentation:
Spatial Genomics & Transcriptomics Market is segmented By Technique, Product, Application, and End-User. By Technique, market is segmented into Spatial Transcriptomics which includes (Immunohistochemistry (IHC), In Situ Hybridization, Sequencing Techniques (Microdissection-based sequencing, In situ sequencing), Microscopy based RNA imaging, Other Spatial Transcriptomics Techniques) and Spatial Genomics Analysis which consists of FLUORESCENCE In Situ Hybridization, Sequencing Techniques, Other Spatial Genomics Analysis Techniques).
According to Product, the market is divided into Instruments, Consumables, and Software. Whereas, By Application, it is segmented as Translational Research, Drug Discovery and Development. Lastly, By End-User, the market is segmented into Academic and Research Institutes, Contract Research Organizations, Pharmaceutical and Biotechnology Companies.
Based On Product, The Consumables Segment Is Accounted As A Major Contributor In The Spatial Genomics & Transcriptomics Market.
The Consumables category is expected to hold a major share of the global Spatial Genomics & Transcriptomics Market in 2022. The main drivers of revenue leadership are recurrent consumption across numerous workflow steps and a wide number of products offers from important vendors. Studying the spatial organization and interactions of cells within intricate biological systems can be facilitated by spatial genomics and transcriptomics, which offer distinct advantages. Unlike conventional genomics techniques, this enables researchers to acquire insights into the spatial distribution of genes and their patterns of expression.
The Translational Research Segment Witnessed Growth At A Rapid Rate.
The translational research segment is projected to grow at a rapid rate in the global Spatial Genomics & Transcriptomics Market. By offering a detailed analysis of the physiology and condition of a disease, the application of spatial omics technologies in translational research may possibly help research by accelerating the introduction of new diagnostic tools and therapies.
Also being used to offer high-throughput data on the organizational structure of cell content from tissues and cell species are spatial genomics and transcriptomics. The study and development of predictive and pharmacogenetic tests that aid in the early detection of serious illnesses are being actively pursued by key stakeholders in light of these potential advantages.
In The Region, The North American Spatial Genomics & Transcriptomics Market Holds A Significant Revenue Share.
The North America Spatial Genomics & Transcriptomics Market is expected to record the major market share in terms of revenue in the near future. This is owing to intentional expenditures in disease pathology research and a greater emphasis on transcriptomics research and development. The introduction of preventative disease through genomics by a number of general hospitals and other concerned organizations, in addition to novel developments and product launches, will contribute to the market's growth.
The increasing prevalence of cancer cases in North American countries is expected to drive demand for cutting-edge diagnostics such as spatial genomics and transcriptomics, fueling market growth. During the projected period, the Asia Pacific region is expected to grow at a profitable pace. The collaboration between regional research institutes with multinational corporations is expected to increase regional revenue production.
Spatial Genomics & Transcriptomics Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 238.84 Mn |
|
Revenue Forecast In 2031 |
USD 667.51 Mn |
|
Growth Rate CAGR |
CAGR of 12.3% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Technique, Product, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
10x Genomics, NanoString Technologies, Illumina, Fluidigm Corporation, PerkinElmer, Akoya Biosciences (formerly known as CytoViva), Spatial Transcriptomics, Dovetail Genomics (Part of Illumina), S2 Genomics, Visiopharm, MGI Tech Co. Ltd., CARTANA, RareCyte, Horizon Discovery Group, and IONpath. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
